An X-ray crystal structure-based understanding of the inhibition of the MDM2-p53 protein-protein interaction by isoindolinones

被引：0

作者：

Anil, B. ^{[1
]}

Blackburn, E. ^{[1
]}

Blackburn, T. ^{[2
]}

Cully, S. ^{[2
]}

Liu, J. ^{[2
]}

Drummond, C. J. ^{[2
]}

Endicott, J. A. ^{[1
]}

Golding, B. T. ^{[3
]}

Griffin, R. J. ^{[2
]}

Haggerty, K. ^{[2
]}

Lunec, J. ^{[2
]}

Newell, D. R. ^{[2
]}

Revill, C. H. ^{[2
]}

Riedinger, C. ^{[1
]}

Watson, A. F. ^{[2
]}

Xu, Q. ^{[2
]}

Zhao, Y. ^{[2
]}

Hardcastle, I. R. ^{[2
]}

Noble, M. E. M. ^{[1
]}

机构：

[1] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England

[2] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[3] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

来源：

EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷

关键词：

D O I：

10.1016/S0959-8049(14)70402-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

276

引用

页码：91 / 92

页数：2

共 50 条

[1] Identification of substituted isoindolinones as potent inhibitors of the MDM2-p53 protein-protein interaction
Watson, Anna
Liu, Junfeng
Armstrong, Elizabeth
Blackburn, Timothy
Endicott, Jane A.
Golding, Bernard T.
Griffin, Roger J.
Lu, Xiaohong
Newell, David R.
Noble, Martin E. M.
Riedinger, Christiane
Lunec, John
Hardcastle, Ian R.
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[2] MDM2-p53 protein-protein interaction inhibitors: A-ring substituted isoindolinones
Watson, Anna F.
Liu, Junfeng
Bennaceur, Karim
Drummond, Catherine J.
Endicott, Jane A.
Golding, Bernard T.
Griffin, Roger J.
Haggerty, Karen
Lu, Xiaohong
McDonnell, James M.
Newell, David R.
Noble, Martin E. M.
Revill, Charlotte H.
Riedinger, Christiane
Xu, Qing
Zhao, Yan
Lunec, John
Hardcastle, Ian R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5916 - 5919
[3] Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction
Chessari, Gianni
Hardcastle, Ian R.
Ahn, Jong Sook
Anil, Burcu
Anscombe, Elizabeth
Bawn, Ruth H.
Bevan, Luke D.
Blackburn, Timothy J.
Buck, Ildiko
Cano, Celine
Carbain, Benoit
Castro, Juan
Cons, Ben
Cully, Sarah J.
Endicott, Jane A.
Fazal, Lynsey
Golding, Bernard T.
Griffin, Roger J.
Haggerty, Karen
Harnor, Suzannah J.
Hearn, Keisha
Hobson, Stephen
Holvey, Rhian S.
Howard, Steven
Jennings, Claire E.
Johnson, Christopher N.
Lunec, John
Miller, Duncan C.
Newell, David R.
Noble, Martin E. M.
Reeks, Judith
Revill, Charlotte H.
Riedinger, Christiane
St Denis, Jeffrey D.
Tamanini, Emiliano
Thomas, Huw
Thompson, Neil T.
Vinkovic, Mladen
Wedge, Stephen R.
Williams, Pamela A.
Wilsher, Nicola E.
Zhang, Bian
Zhao, Yan
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 4071 - 4088
[4] Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction
Kemp, SJ
Hardcastle, IR
Ahmed, SU
Atatreh, NA
Barrett, P
Endicott, JA
Golding, BT
Griffin, RJ
Gruber, J
Hutton, C
Lunec, J
Noble, MEM
Reid, RJ
Riedinger, C
Smyth, LA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2735 - U2736
[5] Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction
Hardcastle, IR
Ahmed, SU
Atkins, H
Calvert, AH
Curtin, NJ
Farnie, G
Golding, BT
Griffin, RJ
Guyenne, S
Hutton, C
Källbad, P
Kemp, SJ
Kitching, MS
Newell, DR
Norbedo, S
Northen, JS
Reid, RJ
Saravanan, K
Willems, HMG
Lunec, J
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) : 1515 - 1520
[6] Inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.
Hardcastle, IR
Ahmed, SU
Barrett, PA
Endicott, JA
Golding, BT
Griffin, RJ
Gruber, J
Hutton, C
Kemp, SJ
Lunec, J
Noble, ME
Riedinger, C
Smyth, LA
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9053S - 9054S
[7] Selective and Potent Morpholinone Inhibitors of the MDM2-p53 Protein-Protein Interaction
Gonzalez, Ana Z.
Eksterowicz, John
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Duquette, Jason
Fox, Brian M.
Fu, Jiasheng
Huang, Xin
Houze, Jonathan B.
Jin, Lixia
Li, Yihong
Li, Zhihong
Ling, Yun
Lo, Mei-Chu
Long, Alexander M.
McGee, Lawrence R.
McIntosh, Joel
McMinn, Dustin L.
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Wortman, Sarah
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Medina, Julio C.
Sun, Daqing
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2472 - 2488
[8] MEDI 147-Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction
Watson, Anna F.
Golding, Bernard T.
Griffin, Roger J.
Hutton, Claire
Liu, Junfeng
Lu, Xiaohong
Lunec, John
Newell, David R.
Valeur, Eric
Hardcastle, Ian R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[9] Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold
Hardcastle, Ian R.
Ahmed, Shafiq U.
Atkins, Helen
Farnie, Gillian
Golding, Bernard T.
Griffin, Roger J.
Guyenne, Sabrina
Hutton, Claire
Kallblad, Per
Kemp, Stuart J.
Kitching, Martin S.
Newell, David R.
Norbedo, Stefano
Northen, Julian S.
Reid, Rebecca J.
Saravanan, K.
Willems, Henriette M. G.
Lunec, John
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6209 - 6221
[10] Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction
Rew, Yosup
Sun, Daqing
De Turiso, Felix Gonzalez-Lopez
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Deignan, Jeffrey
Fox, Brian M.
Gustin, Darin
Huang, Xin
Jiang, Min
Jiao, Xianyun
Jin, Lixia
Kayser, Frank
Kopecky, David J.
Li, Yihong
Lo, Mei-Chu
Long, Alexander M.
Michelsen, Klaus
Oliner, Jonathan D.
Osgood, Tao
Ragains, Mark
Saiki, Anne Y.
Schneider, Steve
Toteva, Maria
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 4936 - 4954

← 1 2 3 4 5 →